This HTML5 document contains 139 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
n9http://dx.doi.org/10.1034/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q44030861
rdf:type
wikibase:Item
schema:description
գիտական հոդված wissenschaftlicher Artikel 2002年学术文章 บทความทางวิทยาศาสตร์ wetenschappelijk artikel 2002年學術文章 мақолаи илмӣ artigo científico מאמר מדעי article científic artículo científico publicado en 2002 vitskapeleg artikkel мақолаи илмӣ vedecký článok 2002年学术文章 articol științific 2002年學術文章 artikull shkencor vědecký článek ২০০২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ artykuł naukowy vetenskaplig artikel 2002年学术文章 teaduslik artikkel 2002年學術文章 2002년 논문 article scientific 2002年學術文章 научна статия vitenskapelig artikkel tudományos cikk mokslinis straipsnis наукова стаття, опублікована в березні 2002 naučni članak tieteellinen artikkeli სამეცნიერო სტატია artigo científico (publicado na 2002) artículu científicu espublizáu en 2002 2002年学术文章 научни чланак artigo científico (publicado na 2002) artikulong pang-agham scientific article επιστημονικό άρθρο 2002年学术文章 2002年學術文章 2002 nî lūn-bûn scienca artikolo научная статья videnskabelig artikel (udgivet 2002) مقالة علمية научни чланак bilimsel makale articolo scientifico 2002年の論文 سائنسی مضمون article scientifique (publié 2002) مقالهٔ علمی bài báo khoa học 2002年學術文章
p:P577
wds:Q44030861-B867131F-CFDE-4672-BD35-2E7F337C3A98
wdt:P577
2002-03-01T00:00:00Z
p:P2860
wds:Q44030861-38E1A2C8-4C3C-4FA7-ACEE-68CDB474C196 wds:Q44030861-391C3AF8-3474-4216-BB94-5908B3DF3033 wds:Q44030861-4C70A9A9-EC0A-48CF-B1E5-111C3105C064 wds:Q44030861-113D862D-52BD-4A80-AAA1-F5B72A28745E wds:Q44030861-1D94AFEF-1EAA-479A-A145-04653A5968A0 wds:Q44030861-3575D605-1EFC-4310-98A9-37132949DA94 wds:Q44030861-376379DE-3008-47D3-95E5-02E825B57531 wds:Q44030861-D8EB865A-4162-4971-95F7-1A1C60497351 wds:Q44030861-EC78986F-B07A-4CF8-81B8-0DA7EF4A1E66 wds:Q44030861-C5CA3F9D-3530-4375-B5F5-9FF236107852 wds:Q44030861-CF9EE2E3-4022-4464-95BD-3DDE5AD009BC wds:Q44030861-ECCCBEC9-C173-48AE-B936-B0E0AB755C8D wds:Q44030861-5FF4A81A-F62B-49A1-BD82-8E97C2FD2AA9 wds:Q44030861-674E226E-4AA0-4204-9FFD-9270D6234746 wds:Q44030861-A972699E-609D-47DE-9292-03AECE4DB895
wdt:P2860
wd:Q71859454 wd:Q71832941 wd:Q68203516 wd:Q28316407 wd:Q70139445 wd:Q60895214 wd:Q34262721 wd:Q70983494 wd:Q72725584 wd:Q68126263 wd:Q25938997 wd:Q74608106 wd:Q42680985 wd:Q28297805 wd:Q69022144
p:P2093
wds:Q44030861-4CD9BB46-7D84-4C5F-8C4B-1ECA1D5C47E3 wds:Q44030861-74F85BDC-06DB-49D3-B12A-9ED17C59B331 wds:Q44030861-6CB9F893-6710-4F06-A48A-DDD95C0A3ACB wds:Q44030861-6F528266-DEFF-4CC6-A348-57D0F98D1B31 wds:Q44030861-C2631A3E-3DF8-4F88-970B-68D68FA7D3BD wds:Q44030861-D0FFE386-7AC1-47B8-8478-2FA17A3F247D wds:Q44030861-D5ADA32D-7DF0-4BDE-B9AC-17FA2464110D wds:Q44030861-FE48DB36-066C-4502-922C-F240BC93CE88 wds:Q44030861-0390C416-F6DA-4D12-9AB2-CD0D403EA49F
wdt:P2093
Samantas E Pavlidis N Nicolaides C Papageogriou E Papadopoulos A Mellou S Economopoulos T Tsatalas C Papasavvas P
rdfs:label
Treatment of intermediate- and high-grade non-Hodgkin's lymphoma using CEOP versus CNOP. Treatment of intermediate- and high-grade non-Hodgkin's lymphoma using CEOP versus CNOP.
skos:prefLabel
Treatment of intermediate- and high-grade non-Hodgkin's lymphoma using CEOP versus CNOP. Treatment of intermediate- and high-grade non-Hodgkin's lymphoma using CEOP versus CNOP.
schema:name
Treatment of intermediate- and high-grade non-Hodgkin's lymphoma using CEOP versus CNOP. Treatment of intermediate- and high-grade non-Hodgkin's lymphoma using CEOP versus CNOP.
p:P50
wds:Q44030861-C00D15FA-0057-493C-B00E-C3A72167A0E4 wds:Q44030861-38DB2FAB-E3E8-4105-98AB-613861A452C0
wdt:P50
wd:Q26338766 wd:Q56432880
p:P1476
wds:Q44030861-BC159A92-30C1-4F00-809F-30B2B622A21A
wdt:P1476
Treatment of intermediate- and high-grade non-Hodgkin's lymphoma using CEOP versus CNOP.
p:P304
wds:Q44030861-8855898E-B11E-41D2-8DAA-D4DA25054435
wdt:P304
135-143
p:P31
wds:Q44030861-9D7E8466-D5AD-497F-A2FC-592B3AEF032A
wdt:P31
wd:Q13442814
p:P698
wds:Q44030861-A4599D6A-FA68-4327-97A5-06927BACD7B3
wdtn:P698
n12:12068793
wdt:P698
12068793
p:P1433
wds:Q44030861-820E61F6-B7C0-43FF-BB7A-60543A5D92FB
wdt:P1433
wd:Q15765799
p:P433
wds:Q44030861-A9725227-D609-4217-AB31-13B77A54780D
p:P478
wds:Q44030861-636CAC98-48C9-46DC-8AEC-189CD2855B69
wdt:P433
3
wdt:P478
68
p:P356
wds:Q44030861-B4CA7E24-2615-476C-AE59-6F0CC0CFA884
wdtn:P356
n9:J.1600-0609.2002.01620.X
wdt:P356
10.1034/J.1600-0609.2002.01620.X